With Clearwater Analytics’ proposed $1.5 billion buy of Enfusion earlier this month, the market for order management systems ...
In a report released yesterday, Michael Infante from Morgan Stanley maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research ...
NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger ...
Morgan Stanley provided investor feedback on Clearwater Analytics (CWAN) following upgrade of the software solution ...
Investing.com -- Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share ...
In other recent news, Clearwater Analytics Holdings has been in the spotlight following a series of developments. The company's acquisition of Enfusion has been hailed as a game-changer by Morgan ...
Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire ...
NYSE:ENFN) Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...
(Reuters) - Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge ...